BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mudd PA, Crawford JC, Turner JS, Souquette A, Reynolds D, Bender D, Bosanquet JP, Anand NJ, Striker DA, Martin RS, Boon ACM, House SL, Remy KE, Hotchkiss RS, Presti RM, O'Halloran JA, Powderly WG, Thomas PG, Ellebedy AH. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv 2020;6:eabe3024. [PMID: 33187979 DOI: 10.1126/sciadv.abe3024] [Cited by in Crossref: 61] [Cited by in F6Publishing: 111] [Article Influence: 30.5] [Reference Citation Analysis]
Number Citing Articles
1 Shaymardanov AM, Antonova OA, Sokol AD, Deinichenko KA, Kazakova PG, Milovanov MM, Zakubansky AV, Akinshina AI, Tsypkina AV, Romanova SV, Muhin VE, Mitrofanov SI, Yudin VS, Yudin SM, Makhotenko AV, Keskinov AA, Kraevoy SA, Snigir EA, Svetlichnyy DV, Skvortsova VI. Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19. Cells 2022;11:2950. [DOI: 10.3390/cells11192950] [Reference Citation Analysis]
2 Daamen AR, Bachali P, Bonham CA, Somerville L, Sturek JM, Grammer AC, Kadl A, Lipsky PE. COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity. Front Immunol 2022;13:989556. [DOI: 10.3389/fimmu.2022.989556] [Reference Citation Analysis]
3 Yao Y, Subedi K, Liu T, Khalasawi N, Pretto-kernahan CD, Wotring JW, Wang J, Yin C, Jiang A, Fu C, Dimitrion P, Li J, Veenstra J, Yi Q, Mckinnon K, Mckinnon JE, Sexton JZ, Zhou L, Mi Q. Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes. Cell Discov 2022;8. [DOI: 10.1038/s41421-022-00453-8] [Reference Citation Analysis]
4 Lai G, Liu H, Deng J, Li K, Xie B. A Novel 3-Gene Signature for Identifying COVID-19 Patients Based on Bioinformatics and Machine Learning. Genes 2022;13:1602. [DOI: 10.3390/genes13091602] [Reference Citation Analysis]
5 Khare K, Pandey R. Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key. Front Immunol 2022;13:973070. [DOI: 10.3389/fimmu.2022.973070] [Reference Citation Analysis]
6 Afewerki S, Stocco TD, Rosa da Silva AD, Aguiar Furtado AS, Fernandes de Sousa G, Ruiz-Esparza GU, Webster TJ, Marciano FR, Strømme M, Zhang YS, Lobo AO. In vitro high-content tissue models to address precision medicine challenges. Mol Aspects Med 2022;:101108. [PMID: 35987701 DOI: 10.1016/j.mam.2022.101108] [Reference Citation Analysis]
7 Iwamura C, Hirahara K, Kiuchi M, Ikehara S, Azuma K, Shimada T, Kuriyama S, Ohki S, Yamamoto E, Inaba Y, Shiko Y, Aoki A, Kokubo K, Hirasawa R, Hishiya T, Tsuji K, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Tsukamoto T, Nakamura S, Urushibara T, Kaneda S, Sakao S, Tobiume M, Suzuki Y, Tsujiwaki M, Kubo T, Hasegawa T, Nakase H, Nishida O, Takahashi K, Baba K, Iizumi Y, Okazaki T, Kimura MY, Yoshino I, Igari H, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Ikehara Y, Yokote K, Nakayama T. Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity. Proc Natl Acad Sci U S A 2022;119:e2203437119. [PMID: 35895716 DOI: 10.1073/pnas.2203437119] [Reference Citation Analysis]
8 Pietzner M, Chua RL, Wheeler E, Jechow K, Willett JDS, Radbruch H, Trump S, Heidecker B, Zeberg H, Heppner FL, Eils R, Mall MA, Richards JB, Sander LE, Lehmann I, Lukassen S, Wareham NJ, Conrad C, Langenberg C. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19. Nat Commun 2022;13:4484. [PMID: 35970849 DOI: 10.1038/s41467-022-31999-6] [Reference Citation Analysis]
9 Lebedeva A, Molodtsov I, Anisimova A, Berestovskaya A, Dukhin O, Elizarova A, Fitzgerald W, Fomina D, Glebova K, Ivanova O, Kalinskaya A, Lebedeva A, Lysenko M, Maryukhnich E, Misyurina E, Protsenko D, Rosin A, Sapozhnikova O, Sokorev D, Shpektor A, Vorobyeva D, Vasilieva E, Margolis L. Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy. IJMS 2022;23:7937. [DOI: 10.3390/ijms23147937] [Reference Citation Analysis]
10 Rybkina K, Davis-Porada J, Farber DL. Tissue immunity to SARS-CoV-2: Role in protection and immunopathology. Immunol Rev 2022. [PMID: 35752871 DOI: 10.1111/imr.13112] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shapiro L, Scherger S, Franco-paredes C, Gharamti AA, Fraulino D, Henao-martinez AF. Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis. Front Pharmacol 2022;13:910516. [DOI: 10.3389/fphar.2022.910516] [Reference Citation Analysis]
12 Awosanya OD, Dadwal UC, Imel EA, Yu Q, Kacena MA. The Impacts of COVID-19 on Musculoskeletal Health. Curr Osteoporos Rep 2022. [PMID: 35723777 DOI: 10.1007/s11914-022-00734-x] [Reference Citation Analysis]
13 Pacheco-Hernández LM, Ramírez-Noyola JA, Gómez-García IA, Ignacio-Cortés S, Zúñiga J, Choreño-Parra JA. Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza. J Interferon Cytokine Res 2022. [PMID: 35674675 DOI: 10.1089/jir.2022.0029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mohammed RN, Tamjidifar R, Rahman HS, Adili A, Ghoreishizadeh S, Saeedi H, Thangavelu L, Shomali N, Aslaminabad R, Marofi F, Tahavvori M, Danishna S, Akbari M, Ercan G. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00856-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Dmytrenko O, Lavine KJ. Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection. Viruses 2022;14:1137. [PMID: 35746609 DOI: 10.3390/v14061137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jalodia R, Antoine D, Braniff RG, Dutta RK, Ramakrishnan S, Roy S. Opioid-Use, COVID-19 Infection, and Their Neurological Implications. Front Neurol 2022;13:884216. [DOI: 10.3389/fneur.2022.884216] [Reference Citation Analysis]
17 Lesueur J, Walachowski S, Barbey S, Cebron N, Lefebvre R, Launay F, Boichard D, Germon P, Corbiere F, Foucras G. Standardized Whole Blood Assay and Bead-Based Cytokine Profiling Reveal Commonalities and Diversity of the Response to Bacteria and TLR Ligands in Cattle. Front Immunol 2022;13:871780. [DOI: 10.3389/fimmu.2022.871780] [Reference Citation Analysis]
18 Smith AP, Williams EP, Plunkett TR, Selvaraj M, Lane LC, Zalduondo L, Xue Y, Vogel P, Channappanavar R, Jonsson CB, Smith AM. Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2. Front Immunol 2022;13:894534. [DOI: 10.3389/fimmu.2022.894534] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhang Y, Shi F, Wang Y, Meng Y, Zhang Q, Wang K, Zeng P, Diao H. Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19. Front Mol Biosci 2022;9:835590. [DOI: 10.3389/fmolb.2022.835590] [Reference Citation Analysis]
20 Turnbull IR, Fuchs A, Remy KE, Kelly MP, Frazier EP, Ghosh S, Chang SW, Mazer MB, Hess A, Leonard JM, Hoofnagle MH, Colonna M, Hotchkiss RS. Dysregulation of the leukocyte signaling landscape during acute COVID-19. PLoS One 2022;17:e0264979. [PMID: 35421120 DOI: 10.1371/journal.pone.0264979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Brownlie D, Rødahl I, Varnaite R, Asgeirsson H, Glans H, Falck-Jones S, Vangeti S, Buggert M, Ljunggren HG, Michaëlsson J, Gredmark-Russ S, Smed-Sörensen A, Marquardt N. Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza. Front Immunol 2022;13:834862. [PMID: 35371005 DOI: 10.3389/fimmu.2022.834862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
23 Li W, Syed F, Yu R, Yang J, Xia Y, Relich RF, Russell PM, Zhang S, Khalili M, Huang L, Kacena MA, Zheng X, Yu Q. Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection. Front Immunol 2022;13:833310. [PMID: 35281051 DOI: 10.3389/fimmu.2022.833310] [Reference Citation Analysis]
24 Coronel MM, Martin KE, Hunckler MD, Kalelkar P, Shah RM, García AJ. Hydrolytically Degradable Microgels with Tunable Mechanical Properties Modulate the Host Immune Response. Small 2022;:e2106896. [PMID: 35274457 DOI: 10.1002/smll.202106896] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk., COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 2022;185:916-938.e58. [PMID: 35216673 DOI: 10.1016/j.cell.2022.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 10.0] [Reference Citation Analysis]
26 Chou J, Thomas PG, Randolph AG. Immunology of SARS-CoV-2 infection in children. Nat Immunol 2022;23:177-85. [PMID: 35105983 DOI: 10.1038/s41590-021-01123-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
27 Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol 2022;23:165-76. [PMID: 35105981 DOI: 10.1038/s41590-021-01091-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 52.0] [Reference Citation Analysis]
28 Mcgonagle D, Kearney MF, O'regan A, O'donnell JS, Quartuccio L, Watad A, Bridgewood C. Therapeutic implications of ongoing alveolar viral replication in COVID-19. The Lancet Rheumatology 2022;4:e135-44. [DOI: 10.1016/s2665-9913(21)00322-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
29 Unterman A, Sumida TS, Nouri N, Yan X, Zhao AY, Gasque V, Schupp JC, Asashima H, Liu Y, Cosme C Jr, Deng W, Chen M, Raredon MSB, Hoehn KB, Wang G, Wang Z, DeIuliis G, Ravindra NG, Li N, Castaldi C, Wong P, Fournier J, Bermejo S, Sharma L, Casanovas-Massana A, Vogels CBF, Wyllie AL, Grubaugh ND, Melillo A, Meng H, Stein Y, Minasyan M, Mohanty S, Ruff WE, Cohen I, Raddassi K, Niklason LE, Ko AI, Montgomery RR, Farhadian SF, Iwasaki A, Shaw AC, van Dijk D, Zhao H, Kleinstein SH, Hafler DA, Kaminski N, Dela Cruz CS; Yale IMPACT Research Team. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat Commun 2022;13:440. [PMID: 35064122 DOI: 10.1038/s41467-021-27716-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
30 Nguyen THO, Cohen CA, Rowntree LC, Bull MB, Hachim A, Kedzierska K, Valkenburg SA. T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants. Front Med (Lausanne) 2021;8:793102. [PMID: 35004764 DOI: 10.3389/fmed.2021.793102] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
31 Garg S, Singh VK, Sonkar SC, Kelkar H, Singh S, Garg S, Arya M, Husain F, Chandra L, Chitkara A, Talukdar T, Goswami B, Koner BC. Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection. Clin Chim Acta 2022;527:11-6. [PMID: 35007527 DOI: 10.1016/j.cca.2022.01.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gagiannis D, Umathum VG, Bloch W, Rother C, Stahl M, Witte HM, Djudjaj S, Boor P, Steinestel K. Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2. Am J Clin Pathol 2022;157:54-63. [PMID: 34463314 DOI: 10.1093/ajcp/aqab087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Chiang KC, Imig JD, Kalantar-Zadeh K, Gupta A. Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis. Curr Opin Nephrol Hypertens 2022;31:36-46. [PMID: 34846312 DOI: 10.1097/MNH.0000000000000750] [Reference Citation Analysis]
34 Singla RK, He X, Chopra H, Tsagkaris C, Shen L, Kamal MA, Shen B. Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources. Front Pharmacol 2021;12:758159. [PMID: 34925017 DOI: 10.3389/fphar.2021.758159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
35 Tian Y, Carpp LN, Miller HER, Zager M, Newell EW, Gottardo R. Single-cell immunology of SARS-CoV-2 infection. Nat Biotechnol 2021. [PMID: 34931002 DOI: 10.1038/s41587-021-01131-y] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
36 Masood KI, Yameen M, Ashraf J, Shahid S, Mahmood SF, Nasir A, Nasir N, Jamil B, Ghanchi NK, Khanum I, Razzak SA, Kanji A, Hussain R, E Rottenberg M, Hasan Z. Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome. Sci Rep 2021;11:22958. [PMID: 34824360 DOI: 10.1038/s41598-021-02489-4] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
37 Lorente JA, Nin N, Villa P, Vasco D, Miguel-Coello AB, Rodriguez I, Herrero R, Peñuelas O, Ruiz-Cabello J, Izquierdo-Garcia JL. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS. Crit Care 2021;25:390. [PMID: 34781986 DOI: 10.1186/s13054-021-03810-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
38 Monserrat J, Asunsolo A, Gómez-Lahoz A, Ortega MA, Gasalla JM, Gasulla Ó, Fortuny-Profitós J, Mazaira-Font FA, Teixidó Román M, Arranz A, Sanz J, Muñoz B, Arévalo-Serrano J, Rodríguez JM, Martínez-A C, Balomenos D, Álvarez-Mon M. Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19. Biomedicines 2021;9:1675. [PMID: 34829906 DOI: 10.3390/biomedicines9111675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Elkholi MH, Alrais ZF, Algouhary AR, Al-Taie MS, Sawwan AA, Khalafalla AA, Beniamein MM, Alkhouly AE, Shoaib MI, Alkholy HE, Abdel Hadi AM, Abu Alkhair AT. Acute kidney injury in ventilated patients with coronavirus disease-2019 pneumonia: A single-center retrospective study. Int J Crit Illn Inj Sci 2021;11:123-33. [PMID: 34760658 DOI: 10.4103/IJCIIS.IJCIIS_194_20] [Reference Citation Analysis]
40 Vick SC, Frutoso M, Mair F, Konecny AJ, Greene E, Wolf CR, Logue JK, Franko NM, Boonyaratanakornkit J, Gottardo R, Schiffer JT, Chu HY, Prlic M, Lund JM. A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections. Sci Adv 2021;7:eabj0274. [PMID: 34757794 DOI: 10.1126/sciadv.abj0274] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
41 Pinski AN, Steffen TL, Zulu MZ, George SL, Dickson A, Tifrea D, Maroney KJ, Tedeschi N, Zhang Y, Scheuermann RH, Pinto AK, Brien JD, Messaoudi I. Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation. J Leukoc Biol 2021. [PMID: 34730254 DOI: 10.1002/JLB.4COVA0121-084RR] [Reference Citation Analysis]
42 Fanning SL, Korngold R, Yang Z, Goldgirsh K, Park S, Zenreich J, Baker M, McKiernan P, Tan M, Zhang B, Donato ML, Perlin DS. Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma. PLoS Pathog 2021;17:e1010025. [PMID: 34714894 DOI: 10.1371/journal.ppat.1010025] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Bonnet B, Cosme J, Dupuis C, Coupez E, Adda M, Calvet L, Fabre L, Saint-Sardos P, Bereiziat M, Vidal M, Laurichesse H, Souweine B, Evrard B. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. EBioMedicine 2021;73:103622. [PMID: 34678611 DOI: 10.1016/j.ebiom.2021.103622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
44 Matsuyama T, Yoshinaga SK, Shibue K, Mak TW. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ 2021. [PMID: 34663907 DOI: 10.1038/s41418-021-00892-y] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
45 Martynova E, Hamza S, Garanina EE, Kabwe E, Markelova M, Shakirova V, Khaertynova IM, Kaushal N, Baranwal M, Rizvanov AA, Urbanowicz RA, Khaiboullina SF. Long Term Immune Response Produced by the SputnikV Vaccine. Int J Mol Sci 2021;22:11211. [PMID: 34681885 DOI: 10.3390/ijms222011211] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
46 Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, Meyer CG. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine 2021;72:103629. [PMID: 34655949 DOI: 10.1016/j.ebiom.2021.103629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Sherwood KR, Nicholl DDM, Fenninger F, Wu V, Wong P, Benedicto V, Cina DP, Wang M, Pobran TD, De Marco ML, Márquez AC, Jassem AN, Sekirov I, Morshed MG, Bardi M, Sekhon M, Keown P, Kadatz M, Lan JH. Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report. Front Immunol 2021;12:753558. [PMID: 34630432 DOI: 10.3389/fimmu.2021.753558] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Vono M, Huttner A, Lemeille S, Martinez-Murillo P, Meyer B, Baggio S, Sharma S, Thiriard A, Marchant A, Godeke GJ, Reusken C, Alvarez C, Perez-Rodriguez F, Eckerle I, Kaiser L, Loevy N, Eberhardt CS, Blanchard-Rohner G, Siegrist CA, Didierlaurent AM. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. Cell Rep 2021;37:109773. [PMID: 34587479 DOI: 10.1016/j.celrep.2021.109773] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Yang Q, Wen Y, Qi F, Gao X, Chen W, Xu G, Wei C, Wang H, Tang X, Lin J, Zhao J, Zhang M, Zhang S, Zhang Z. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19. J Immunol 2021;207:1848-56. [PMID: 34452933 DOI: 10.4049/jimmunol.2100228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
50 Sinha P, Bos LD. Pathophysiology of the Acute Respiratory Distress Syndrome: Insights from Clinical Studies. Crit Care Clin 2021;37:795-815. [PMID: 34548134 DOI: 10.1016/j.ccc.2021.05.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Porcher L, Bruckmeier S, Burbano SD, Finnell JE, Gorny N, Klett J, Wood SK, Kelly MP. Aging triggers an upregulation of a multitude of cytokines in the male and especially the female rodent hippocampus but more discrete changes in other brain regions. J Neuroinflammation 2021;18:219. [PMID: 34551810 DOI: 10.1186/s12974-021-02252-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
52 Youngs J, Provine NM, Lim N, Sharpe HR, Amini A, Chen YL, Luo J, Edmans MD, Zacharopoulou P, Chen W, Sampson O, Paton R, Hurt WJ, Duncan DA, McNaughton AL, Miao VN, Leaver S, Wyncoll DLA, Ball J, Hopkins P, Skelly DT, Barnes E, Dunachie S, Ogg G, Lambe T, Pavord I, Shalek AK, Thompson CP, Xue L, Macallan DC, Goulder P, Klenerman P, Bicanic T; Oxford Immunology Network Covid-19 response T cell Consortium., Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team. Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients. PLoS Pathog 2021;17:e1009804. [PMID: 34529726 DOI: 10.1371/journal.ppat.1009804] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
53 Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, Nold MF. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci Immunol 2021;6:eabd0205. [PMID: 34533977 DOI: 10.1126/sciimmunol.abd0205] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
54 Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, Sisti S, Criscuolo E, Spreafico R, Long JM, Ambrosi A, Liu E, Frangipane V, Saracino L, Bozzini S, Marongiu L, Facchini FA, Bottazzi A, Fossali T, Colombo R, Clementi M, Tagliabue E, Chou J, Pontiroli AE, Meloni F, Wack A, Mancini N, Zanoni I. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell 2021;184:4953-4968.e16. [PMID: 34492226 DOI: 10.1016/j.cell.2021.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
55 . Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol 2021;6:eabh2259. [PMID: 34446527 DOI: 10.1126/sciimmunol.abh2259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 55] [Article Influence: 12.0] [Reference Citation Analysis]
56 Zanoni I. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19? Curr Opin Virol 2021;50:119-27. [PMID: 34454352 DOI: 10.1016/j.coviro.2021.08.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Sarma A, Christenson SA, Byrne A, Mick E, Pisco AO, DeVoe C, Deiss T, Ghale R, Zha BS, Tsitsiklis A, Jauregui A, Moazed F, Detweiler AM, Spottiswoode N, Sinha P, Neff N, Tan M, Serpa PH, Willmore A, Ansel KM, Wilson JG, Leligdowicz A, Siegel ER, Sirota M, DeRisi JL, Matthay MA, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Erle DJ, Calfee CS, Langelier CR; COMET Consortium. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS. Nat Commun 2021;12:5152. [PMID: 34446707 DOI: 10.1038/s41467-021-25040-5] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
58 Wei F, Gao C, Wang Y. The role of influenza A virus-induced hypercytokinemia. Crit Rev Microbiol 2021;:1-17. [PMID: 34353210 DOI: 10.1080/1040841X.2021.1960482] [Reference Citation Analysis]
59 Sealy RE, Hurwitz JL. Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study. Microorganisms 2021;9:1643. [PMID: 34442723 DOI: 10.3390/microorganisms9081643] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
60 Badimon L, Robinson EL, Jusic A, Carpusca I, deWindt LJ, Emanueli C, Ferdinandy P, Gu W, Gyöngyösi M, Hackl M, Karaduzovic-Hadziabdic K, Lustrek M, Martelli F, Nham E, Potočnjak I, Satagopam V, Schneider R, Thum T, Devaux Y. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovasc Res 2021;117:1823-40. [PMID: 33839767 DOI: 10.1093/cvr/cvab094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 2021:S0092-8674(21)00882-5. [PMID: 34352228 DOI: 10.1016/j.cell.2021.07.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
62 Sindelar M, Stancliffe E, Schwaiger-Haber M, Anbukumar DS, Adkins-Travis K, Goss CW, O'Halloran JA, Mudd PA, Liu WC, Albrecht RA, García-Sastre A, Shriver LP, Patti GJ. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med 2021;2:100369. [PMID: 34308390 DOI: 10.1016/j.xcrm.2021.100369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Syed F, Li W, Relich RF, Russell PM, Zhang S, Zimmerman MK, Yu Q. Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19. J Infect Dis 2021;224:60-9. [PMID: 33885811 DOI: 10.1093/infdis/jiab167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
64 Choreño-Parra JA, Jiménez-Álvarez LA, Ramírez-Martínez G, Cruz-Lagunas A, Thapa M, Fernández-López LA, Carnalla-Cortés M, Choreño-Parra EM, Mena-Hernández L, Sandoval-Vega M, Hernández-Montiel EM, Hernández-García DL, Ramírez-Noyola JA, Reyes-López CE, Domínguez-Faure A, Zamudio-López GY, Márquez-García E, Moncada-Morales A, Mendoza-Milla C, Cervántes-Rosete D, Muñoz-Torrico M, Luna-Rivero C, García-Latorre EA, Guadarrama-Ortíz P, Ávila-Moreno F, Domínguez-Cherit G, Rodríguez-Reyna TS, Mudd PA, Hernández-Cárdenas CM, Khader SA, Zúñiga J. Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019. J Infect Dis 2021;224:21-30. [PMID: 33668070 DOI: 10.1093/infdis/jiab113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
65 Mehta P, Fajgenbaum DC. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate. Curr Opin Rheumatol 2021;33:419-30. [PMID: 34264880 DOI: 10.1097/BOR.0000000000000822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, Antoranz A, Arijs I, Boeckx B, Bosisio FM, Casaer M, Dauwe D, De Wever W, Dooms C, Dreesen E, Emmaneel A, Filtjens J, Gouwy M, Gunst J, Hermans G, Jansen S, Lagrou K, Liston A, Lorent N, Meersseman P, Mercier T, Neyts J, Odent J, Panovska D, Penttila PA, Pollet E, Proost P, Qian J, Quintelier K, Raes J, Rex S, Saeys Y, Sprooten J, Tejpar S, Testelmans D, Thevissen K, Van Buyten T, Vandenhaute J, Van Gassen S, Velásquez Pereira LC, Vos R, Weynand B, Wilmer A, Yserbyt J, Garg AD, Matthys P, Wouters C, Lambrechts D, Wauters E, Wauters J. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun 2021;12:4117. [PMID: 34226537 DOI: 10.1038/s41467-021-24360-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
67 Silverstein NJ, Wang Y, Manickas-Hill Z, Carbone C, Dauphin A, Boribong BP, Loiselle M, Davis J, Leonard MM, Kuri-Cervantes L, Meyer NJ, Betts MR, Li JZ, Walker B, Yu XG, Yonker LM, Luban J; MGH COVID-19 Collection & Processing Team. Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection. medRxiv 2021:2021. [PMID: 33469605 DOI: 10.1101/2021.01.14.21249839] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
68 Sampaio NG, Chauveau L, Hertzog J, Bridgeman A, Fowler G, Moonen JP, Dupont M, Russell RA, Noerenberg M, Rehwinkel J. The RNA sensor MDA5 detects SARS-CoV-2 infection. Sci Rep 2021;11:13638. [PMID: 34211037 DOI: 10.1038/s41598-021-92940-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
69 Karki R, Kanneganti TD. The 'cytokine storm': molecular mechanisms and therapeutic prospects. Trends Immunol 2021;42:681-705. [PMID: 34217595 DOI: 10.1016/j.it.2021.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
70 Fakhoury HMA, Kvietys PR, Shakir I, Shams H, Grant WB, Alkattan K. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 2021;13:2216. [PMID: 34203190 DOI: 10.3390/nu13072216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
71 Ganesh GV, Mohanram RK. Metabolic reprogramming and immune regulation in viral diseases. Rev Med Virol 2021;:e2268. [PMID: 34176174 DOI: 10.1002/rmv.2268] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
72 Morton B, Barnes KG, Anscombe C, Jere K, Matambo P, Mandolo J, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda NP, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC; Blantyre COVID-19 Consortium. Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa. Nat Commun 2021;12:3554. [PMID: 34117221 DOI: 10.1038/s41467-021-23267-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Kvietys PR, Fakhoury HMA, Kadan S, Yaqinuddin A, Al-Mutairy E, Al-Kattan K. COVID-19: Lung-Centric Immunothrombosis. Front Cell Infect Microbiol 2021;11:679878. [PMID: 34178722 DOI: 10.3389/fcimb.2021.679878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
74 Hernández-Cárdenas C, Lugo-Goytia G, Hernández-García D, Pérez-Padilla R. Comparison of the clinical characteristics and mortality in acute respiratory distress syndrome due to COVID-19 versus due to Influenza A-H1N1pdm09. Med Intensiva 2021:S0210-5691(21)00119-4. [PMID: 34175138 DOI: 10.1016/j.medin.2021.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Bibert S, Guex N, Lourenco J, Brahier T, Papadimitriou-Olivgeris M, Damonti L, Manuel O, Liechti R, Götz L, Tschopp J, Quinodoz M, Vollenweider P, Pagani JL, Oddo M, Hügli O, Lamoth F, Erard V, Voide C, Delorenzi M, Rufer N, Candotti F, Rivolta C, Boillat-Blanco N, Bochud PY; RegCOVID Study Group. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol 2021;12:666163. [PMID: 34135895 DOI: 10.3389/fimmu.2021.666163] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
76 Nagaraja S, Jain D, Kesavardhana S. Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats. J Leukoc Biol 2021. [PMID: 34057760 DOI: 10.1002/JLB.4COVHR0221-093RR] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
77 Zhang J, Huang X, Ding D, Tao Z. Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases. Exp Hematol Oncol 2021;10:34. [PMID: 34059141 DOI: 10.1186/s40164-021-00228-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
78 Sridhar S, Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology 2021;26:652-65. [PMID: 34041821 DOI: 10.1111/resp.14091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
79 Chilunda V, Martinez-Aguado P, Xia LC, Cheney L, Murphy A, Veksler V, Ruiz V, Calderon TM, Berman JW. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19. Front Immunol 2021;12:665773. [PMID: 34108966 DOI: 10.3389/fimmu.2021.665773] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
80 Dewi IM, Janssen NA, Rosati D, Bruno M, Netea MG, Brüggemann RJ, Verweij PE, van de Veerdonk FL. Invasive pulmonary aspergillosis associated with viral pneumonitis. Curr Opin Microbiol 2021;62:21-7. [PMID: 34034082 DOI: 10.1016/j.mib.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
81 Lowery SA, Sariol A, Perlman S. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19. Cell Host Microbe 2021;29:1052-62. [PMID: 34022154 DOI: 10.1016/j.chom.2021.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
82 Sangha G, Kaushik K, Robinson A, Ainge T, Dungarwalla M, Chakraborty A. Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19. Br J Haematol 2021;194:686-8. [PMID: 33993500 DOI: 10.1111/bjh.17533] [Reference Citation Analysis]
83 Root-Bernstein R. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines (Basel) 2021;9:474. [PMID: 34066697 DOI: 10.3390/vaccines9050474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
84 Roussel M, Ferrant J, Reizine F, Le Gallou S, Dulong J, Carl S, Lesouhaitier M, Gregoire M, Bescher N, Verdy C, Latour M, Bézier I, Cornic M, Vinit A, Monvoisin C, Sawitzki B, Leonard S, Paul S, Feuillard J, Jeannet R, Daix T, Tiwari VK, Tadié JM, Cogné M, Tarte K. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection. Cell Rep Med 2021;2:100291. [PMID: 33977279 DOI: 10.1016/j.xcrm.2021.100291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Dhindsa S, Zhang N, McPhaul MJ, Wu Z, Ghoshal AK, Erlich EC, Mani K, Randolph GJ, Edwards JR, Mudd PA, Diwan A. Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19. JAMA Netw Open 2021;4:e2111398. [PMID: 34032853 DOI: 10.1001/jamanetworkopen.2021.11398] [Cited by in Crossref: 12] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
86 Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021;17:315-32. [PMID: 33903743 DOI: 10.1038/s41584-021-00608-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
87 Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia (Nathan) 2021;13:5. [PMID: 33894790 DOI: 10.1186/s41479-021-00083-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
88 Choreño-Parra JA, Jiménez-Álvarez LA, Cruz-Lagunas A, Rodríguez-Reyna TS, Ramírez-Martínez G, Sandoval-Vega M, Hernández-García DL, Choreño-Parra EM, Balderas-Martínez YI, Martinez-Sánchez ME, Márquez-García E, Sciutto E, Moreno-Rodríguez J, Barreto-Rodríguez JO, Vázquez-Rojas H, Centeno-Sáenz GI, Alvarado-Peña N, Salinas-Lara C, Sánchez-Garibay C, Galeana-Cadena D, Hernández G, Mendoza-Milla C, Domínguez A, Granados J, Mena-Hernández L, Pérez-Buenfil LÁ, Domínguez-Cheritt G, Cabello-Gutiérrez C, Luna-Rivero C, Salas-Hernández J, Santillán-Doherty P, Regalado J, Hernández-Martínez A, Orozco L, Ávila-Moreno F, García-Latorre EA, Hernández-Cárdenas CM, Khader SA, Zlotnik A, Zúñiga J. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front Immunol 2021;12:593595. [PMID: 33995342 DOI: 10.3389/fimmu.2021.593595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
89 David P, Hansen FJ, Bhat A, Weber GF. An overview of proteomic methods for the study of 'cytokine storms'. Expert Rev Proteomics 2021;18:83-91. [PMID: 33849358 DOI: 10.1080/14789450.2021.1911652] [Reference Citation Analysis]
90 Stanczak MA, Sanin DE, Apostolova P, Nerz G, Lampaki D, Hofmann M, Steinmann D, Krohn-Grimberghe M, Thimme R, Mittler G, Waller CF, Pearce EJ, Pearce EL. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals. Nat Commun 2021;12:2133. [PMID: 33837219 DOI: 10.1038/s41467-021-22449-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
91 Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021;19:425-41. [PMID: 33824495 DOI: 10.1038/s41579-021-00542-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
92 Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health 2021;14:100251. [PMID: 33842898 DOI: 10.1016/j.bbih.2021.100251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
93 Mazer MB, Davitt E, Turnbull IR, Caldwell CC, Brakenridge SC, Remy KE, Hotchkiss RS. In Vitro-Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019. Crit Care Explor 2021;3:e0378. [PMID: 33834168 DOI: 10.1097/CCE.0000000000000378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Sposito B, Broggi A, Pandolfi L, Crotta S, Ferrarese R, Sisti S, Clementi N, Ambrosi A, Liu E, Frangipane V, Saracino L, Marongiu L, Facchini FA, Bottazzi A, Fossali T, Colombo R, Clementi M, Tagliabue E, Pontiroli AE, Meloni F, Wack A, Mancini N, Zanoni I. Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients. bioRxiv 2021:2021. [PMID: 33821280 DOI: 10.1101/2021.03.30.437173] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
95 Vick SC, Frutoso M, Mair F, Konecny AJ, Greene E, Wolf CR, Logue JK, Boonyaratanakornkit J, Gottardo R, Schiffer JT, Chu HY, Prlic M, Lund JM. A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections. medRxiv 2021:2021. [PMID: 33791720 DOI: 10.1101/2021.03.25.21254376] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Thwaites RS, Sanchez Sevilla Uruchurtu A, Siggins MK, Liew F, Russell CD, Moore SC, Fairfield C, Carter E, Abrams S, Short CE, Thaventhiran T, Bergstrom E, Gardener Z, Ascough S, Chiu C, Docherty AB, Hunt D, Crow YJ, Solomon T, Taylor GP, Turtle L, Harrison EM, Dunning J, Semple MG, Baillie JK, Openshaw PJ; ISARIC4C investigators. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol 2021;6:eabg9873. [PMID: 33692097 DOI: 10.1126/sciimmunol.abg9873] [Cited by in Crossref: 29] [Cited by in F6Publishing: 71] [Article Influence: 29.0] [Reference Citation Analysis]
97 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
98 Ombrello MJ, Schulert GS. COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome? Transl Res 2021;232:1-12. [PMID: 33684592 DOI: 10.1016/j.trsl.2021.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
99 Cao L, Lee S, Krings JG, Rauseo AM, Reynolds D, Presti R, Goss C, Mudd PA, O'Halloran JA, Wang L. Asthma in patients with suspected and diagnosed coronavirus disease 2019. Ann Allergy Asthma Immunol 2021;126:535-541.e2. [PMID: 33639262 DOI: 10.1016/j.anai.2021.02.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
100 Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O'Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 33655244 DOI: 10.1101/2021.02.22.432177] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
101 Snider JM, You JK, Wang X, Snider AJ, Hallmark B, Seeds MC, Sergeant S, Johnstone L, Wang Q, Sprissler R, Zhang HH, Luberto C, Kew RR, Hannun YA, McCall CE, Yao G, Del Poeta M, Chilton FH. Group IIA Secreted Phospholipase A 2 Plays a Central Role in the Pathobiology of COVID-19. medRxiv 2021:2021. [PMID: 33655264 DOI: 10.1101/2021.02.22.21252237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
102 Root-Bernstein R. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Int J Mol Sci 2021;22:2108. [PMID: 33672738 DOI: 10.3390/ijms22042108] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 27.0] [Reference Citation Analysis]
103 Morton B, Barnes KG, Anscombe C, Jere K, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda N, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC. In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profiles. medRxiv 2021:2021. [PMID: 33619502 DOI: 10.1101/2021.02.15.21251753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Turnbull I, Fuchs A, Remy K, Kelly M, Frazier E, Ghosh S, Chang SW, Mazer M, Hess A, Leonard J, Hoofnagle M, Colonna M, Hotchkiss R. Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19. Res Sq 2021:rs. [PMID: 33619472 DOI: 10.21203/rs.3.rs-244150/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Sindelar M, Stancliffe E, Schwaiger-Haber M, Anbukumar DS, Albrecht RA, Liu WC, Travis KA, García-Sastre A, Shriver LP, Patti GJ. Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity. medRxiv 2021:2021. [PMID: 33564793 DOI: 10.1101/2021.02.05.21251173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
106 Rao Y, Wang TY, Qin C, Espinosa B, Liu Q, Ekanayake A, Zhao J, Savas AC, Zhang S, Zarinfar M, Liu Y, Zhu W, Graham NA, Jiang T, Zhang C, Feng P. Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection. bioRxiv 2021:2021. [PMID: 33564769 DOI: 10.1101/2021.02.05.429959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
107 Meier IB, Vieira Ligo Teixeira C, Tarnanas I, Mirza F, Rajendran L. Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force. Brain Commun 2021;3:fcab012. [PMID: 34222864 DOI: 10.1093/braincomms/fcab012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Latreille E, Lee WL. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses. 2021;13. [PMID: 33499234 DOI: 10.3390/v13020161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
109 Syed F, Li W, Relich RF, Russell PM, Zhang S, Zimmerman MK, Yu Q. Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19. medRxiv 2021:2021. [PMID: 33501465 DOI: 10.1101/2021.01.19.21250115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Turner JS, Day A, Alsoussi WB, Liu Z, O'Halloran JA, Presti RM, Patterson BK, Whelan SPJ, Ellebedy AH, Mudd PA. SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response. Front Immunol 2020;11:618402. [PMID: 33488630 DOI: 10.3389/fimmu.2020.618402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
111 Bobkova S, Zhukov A, Protsenko D, Samoylenko V, Tyurin I. Critical appraisal of the "cytokine storm" concept in new coronavirus disease COVID-19. Review. Annals of critical care 2021. [DOI: 10.21320/1818-474x-2021-1-57-68] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]